Then, the correlation between the ADARB1 expression and patients’ prognosis was analyzed in several GBM datasets using the Kaplan-Meier plotter of Drugsurv (Amelio et al., 2014) and PrognoScan (Mizuno et al., 2009). Here, ADARB1 is linked to glioblastoma.